CO5200845A1 - Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina - Google Patents

Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina

Info

Publication number
CO5200845A1
CO5200845A1 CO00067158A CO00067158A CO5200845A1 CO 5200845 A1 CO5200845 A1 CO 5200845A1 CO 00067158 A CO00067158 A CO 00067158A CO 00067158 A CO00067158 A CO 00067158A CO 5200845 A1 CO5200845 A1 CO 5200845A1
Authority
CO
Colombia
Prior art keywords
pyridin
ethoxy
phenyl
butanoic acid
methylamino
Prior art date
Application number
CO00067158A
Other languages
English (en)
Inventor
Peter J Manley
William H Miller
Irene N Uzinkas
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5200845A1 publication Critical patent/CO5200845A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto según la fórmula (l)<EMI FILE="00067158_1" ID="1" IMF=JPEG >en el queR1 es Het- o Ar;R2 es<EMI FILE="00067158_2" ID="2" IMF=JPEG >o una de sus sales farmacéuticamente aceptables.Un compuesto, que es:ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-il]-1-etoxi]-fenil]-3-[4-(trifluorometil)fenil]butanoico,ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-il]-etoxi]-fenil]-3- [4-[(N-metil-N-fenilamino)carbonil]-1,3-oxazol-2-il]butanoico;ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-iI]-1-etoxi]-fenil]- 3-[4-[(morfolin-4-il)carbonil]-1,3-oxazol-2-il]butanoico;ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-il]-1-etoxi]-fenil]-3-[4-[[N-metil-N-(2,2,2-trifluoroetil)amino]carbonil]-1,3-oxazol-2-il]butanoico;ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-il]-1-etoxi]-fenil]- 3-[4-(trifluorometil)tiazol-2-il]butanoico;ácido ( + )-4-[4[2-[6-(metilamino)piridin-2-il]-1-etoxi]-feniI]-3-(3-metiltiazol-2-il)butanoico; ácido ( S )-3-(3-fluorofenil)-4-[4-[2-(5,6,7,8-tetrahidro-1,8 -naftiridin-2-il)etoxi]fenil]butanoico;ácido ( + )-4-[4-[2-[6-(metilamino)piridin-2-il]-etoxi]-fenil]- 3-(piridin-3-il)butanoico;ácido ( S )-4-[4-[2-[6-(metilamino)piridin-2-il]-etoxi]-fenil]-3-(piridin-3-il)butanoico;oácido ( S )-3-(piridin-3-il)-4-[4-[2-(5,6,7,8-tetrahidro -1,8-naftiridin-2-il )etoxi]fenil]butanoico;o una de sus sales farmacéuticamente aceptables.
CO00067158A 1999-09-07 2000-09-06 Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina CO5200845A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15278099P 1999-09-07 1999-09-07

Publications (1)

Publication Number Publication Date
CO5200845A1 true CO5200845A1 (es) 2002-09-27

Family

ID=22544416

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00067158A CO5200845A1 (es) 1999-09-07 2000-09-06 Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina

Country Status (29)

Country Link
EP (1) EP1218005B1 (es)
JP (1) JP4685307B2 (es)
KR (1) KR100711170B1 (es)
CN (1) CN1236767C (es)
AR (1) AR025589A1 (es)
AT (1) ATE284870T1 (es)
AU (1) AU768918B2 (es)
BR (1) BR0013749A (es)
CA (1) CA2384671A1 (es)
CO (1) CO5200845A1 (es)
CZ (1) CZ2002822A3 (es)
DE (1) DE60016769T2 (es)
EG (1) EG24179A (es)
ES (1) ES2234658T3 (es)
GC (1) GC0000203A (es)
HK (1) HK1049110B (es)
HU (1) HUP0202710A3 (es)
IL (2) IL148325A0 (es)
MX (1) MXPA02002455A (es)
NO (1) NO322109B1 (es)
NZ (1) NZ517296A (es)
PE (1) PE20010582A1 (es)
PL (1) PL200404B1 (es)
PT (1) PT1218005E (es)
TR (1) TR200200614T2 (es)
TW (1) TWI255813B (es)
UY (1) UY26329A1 (es)
WO (1) WO2001017959A2 (es)
ZA (1) ZA200201780B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531494B1 (en) 2001-08-29 2003-03-11 Pharmacia Corporation Gem-substituted αvβ3 antagonists
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
EP1721905A4 (en) * 2004-03-05 2009-11-18 Taisho Pharmaceutical Co Ltd THIAZOLE DERIVATIVE
CN103097385B (zh) 2010-07-14 2016-08-03 诺华股份有限公司 Ip受体激动剂杂环化合物
TW201335160A (zh) 2012-01-13 2013-09-01 Novartis Ag Ｉｐ受體激動劑之雜環化合物
CN105189500A (zh) 2013-02-13 2015-12-23 诺华股份有限公司 Ip受体激动剂杂环化合物
CN108675954A (zh) * 2018-04-03 2018-10-19 爱斯特（成都）生物制药股份有限公司 2-氨基-3-羟甲基吡啶的一种制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08325264A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規２−芳香環置換−３−フェニルプロピオン酸またはアクリル酸誘導体
JPH08325263A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規２−アミノ−３−フェニルプロピオン酸誘導体
JP2000502708A (ja) * 1995-12-29 2000-03-07 スミスクライン・ビーチャム・コーポレイション ビトロネクチン受容体拮抗物質
AU8750298A (en) * 1997-08-28 1999-03-22 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
AR015446A1 (es) * 1997-09-19 2001-05-02 Smithkline Beecham Corp Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios
UY25421A1 (es) * 1998-03-10 2001-07-31 Smithkline Beecham Corp Antagonistas de receptor de vitronectina
WO2000009503A1 (en) * 1998-08-13 2000-02-24 Merck & Co., Inc. Integrin receptor antagonists

Also Published As

Publication number Publication date
AU768918B2 (en) 2004-01-08
UY26329A1 (es) 2001-07-31
EP1218005A4 (en) 2002-10-09
CN1236767C (zh) 2006-01-18
JP4685307B2 (ja) 2011-05-18
WO2001017959A3 (en) 2001-05-10
IL148325A0 (en) 2002-09-12
KR100711170B1 (ko) 2007-04-27
EG24179A (en) 2008-09-28
TR200200614T2 (tr) 2002-07-22
NO20021113D0 (no) 2002-03-06
DE60016769T2 (de) 2005-11-24
ES2234658T3 (es) 2005-07-01
GC0000203A (en) 2006-03-29
EP1218005B1 (en) 2004-12-15
CN1377269A (zh) 2002-10-30
MXPA02002455A (es) 2002-07-02
PE20010582A1 (es) 2001-06-23
HK1049110A1 (en) 2003-05-02
NO322109B1 (no) 2006-08-14
ATE284870T1 (de) 2005-01-15
WO2001017959A2 (en) 2001-03-15
KR20020027624A (ko) 2002-04-13
AR025589A1 (es) 2002-12-04
CZ2002822A3 (cs) 2002-07-17
JP2003508516A (ja) 2003-03-04
BR0013749A (pt) 2003-06-10
IL148325A (en) 2007-06-03
NO20021113L (no) 2002-05-03
HK1049110B (zh) 2005-07-22
DE60016769D1 (de) 2005-01-20
PL354176A1 (en) 2003-12-29
PL200404B1 (pl) 2009-01-30
EP1218005A2 (en) 2002-07-03
AU7354300A (en) 2001-04-10
TWI255813B (en) 2006-06-01
ZA200201780B (en) 2003-05-28
NZ517296A (en) 2003-11-28
HUP0202710A2 (hu) 2002-12-28
PT1218005E (pt) 2005-05-31
HUP0202710A3 (en) 2003-06-30
CA2384671A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
HK1086267A1 (en) Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
BRPI0114870B8 (pt) uso de 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-amino)fenil]-benzamida para a fabricação de composições farmacêuticas para tratamento de tumores estromais gastrointestinais
AR049769A1 (es) Derivados de pirazolo(1,5-a)pirimidin 7-il-amina para utilizarse en el tratamiento de enfermedades dependientes de la quinasa de proteina
DE60142469D1 (de) Imidinderivate als antineoplastika
RU2009125019A (ru) Производные карбоновой кислоты
AR087241A2 (es) Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica
PE20010815A1 (es) Uso de inhibidores de 3`,5&#39;-guanosinmonofosfato ciclico fosfodiesterasa para el tratamiento de la hipertension pulmonar
RU2007132262A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
PE20040987A1 (es) Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf)
AR050436A1 (es) Inhibidores de azaindol de mtp y apob
ATE284860T1 (de) Neue verwendung von phenylheteroalkylamin- derivaten
BR0108870A (pt) Sais cloridrato de 5-[4-[2-(n-metil-n-(2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
BRPI0606768A2 (pt) forma de dosagem oral compreendendo rosiglitazona
AR023564A1 (es) Una forma polimorfica de sal del acido maleico derivado del tiazolidina-2,4 diona, una composicion farmaceutica y el uso del mismo para la fabricacion deun medicamento
CO5200845A1 (es) Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
SE9803518D0 (sv) Novel compounds
FI911885A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2,9-disubstituoitujen 3-/2-/4-(6-fluori-1,2-bentsisoksatsol-3-yyli)-piperidinyyli/etyyli/-4H-pyrido/1,2-a/pyrimidin-4-onien valmistamiseksi
HK1073311A1 (en) Derivatives of 4-(thioxanthene-9-ylidene)-piperid ine or acridine and its use in the manufacture of a medicament
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
RU2426734C2 (ru) Пиразолопиридины и их аналоги
AR045330A1 (es) Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla
PE20040916A1 (es) Diamidas de acido pirimidin-4,6-dicarboxilico como inhibidores selectivos de mmp-13
SE9904412D0 (sv) Comminuted form

Legal Events

Date Code Title Description
FD Application lapsed